Clinical Advances in GLP-1 Receptor Target: First Step of STEP Series Study
CK Note: The latest evidence from clinical trials supports the efficacy and tolerability of glucagon-like peptide-1 (GLP-1) receptor agonists as effective weight loss medications. Although initially developed as hypoglycemic agents for type 2 diabetes patients, research over the past 30 years has shown that GLP-1 receptor agonists can act in the central nervous system to … Read more